EurekAlert!

C-Path’s pioneering neuroscience workshop transforms the landscape of neurological disorder therapies

Critical Path Institute (C-Path) is pleased to announce the release of a new peer-reviewed publication, titled “Transforming Drug Development for Neurological Disorders: Proceedings from a ...
EurekAlert!

C-Path’s translational therapeutics accelerator announces new grant award for drug development project in type 1 diabetes

TUCSON, Ariz., June 18, 2025 — Critical Path Institute’s® (C-Path) Translational Therapeutics Accelerator (TRxA) proudly announced today a $250,000 grant award aimed at developing a novel treatment ...
Arizona Daily Star

Tucson-based Critical Path Institute emerging as top drug-research organization

The Tucson-based Critical Path Institute has no laboratories, no drug chemists, no patent lawyers. Yet the nonprofit is arguably one of the most important emerging drug-research organizations in the ...
News Medical

C-Path secures FDA Grant for new public-private partnership to benefit people with rare neurodegenerative diseases

Critical Path Institute (C-Path) has announced it will serve as the convener of the Critical Path for Rare Neurodegenerative Diseases (CP-RND), a new public-private partnership (PPP) to benefit people ...
News Medical

C-Path and CDISC release global Therapeutic Area Standard for HIV research

The Critical Path Institute (C-Path) and CDISC are pleased to announce the release of a global Therapeutic Area Standard that specifies how to structure commonly collected data and outcome ...
PR Newswire

C-Path's Disease Modeling Coalition Begins Global Pediatric IBD Work from European Hub

AMSTERDAM, Oct. 16, 2025 /PRNewswire/ -- Critical Path Institute ® (C-Path) today announced the official launch of the Critical Path Disease Modeling Coalition (CP-DMC) on pediatric inflammatory bowel ...